Mutations of the Cx43 Gene in Non-Small Cell Lung Cancer: Association with Aberrant Localization of Cx43 Protein

Jung-Chien Chen1,2,3, Kun-Tu Yeh4,5, Yueh-Min Lin6,7

  • 1Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.

PubMed

Insights

Connexin43 (Cx43) gene mutations were identified in human lung cancer, suggesting Cx43 acts as a tumor suppressor. Aberrant Cx43 protein localization correlated with enhanced lung cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Connexin43 (Cx43) is implicated as a tumor suppressor gene, with re-expression of wild-type Cx43 reducing tumor cell malignancy.
  • The specific role of Cx43 gene expression in human lung tumorigenesis requires further elucidation.

Purpose of the Study:

  • To investigate the presence and functional significance of Cx43 gene mutations in human lung cancer.
  • To determine the association between Cx43 protein expression, localization, and non-small cell lung cancer (NSCLC) progression.

Main Methods:

  • Immunohistochemistry and direct DNA sequencing were employed to analyze Cx43 protein expression and gene mutations in 165 primary lung cancer tissues.
  • Functional analysis involved transfecting CL-3 human lung cancer cells with wild-type and mutant Cx43 genes.

Main Results:

  • Aberrant nuclear and cytoplasmic localization of Cx43 protein was observed in 14 out of 165 NSCLC patients.
  • Cx43 gene mutations were detected in patients with aberrant Cx43 localization, and these mutations enhanced lung cancer cell proliferation upon transfection.

Conclusions:

  • This study provides the first evidence of Cx43 gene mutations in human lung neoplasms, supporting its role as a potential tumor suppressor in a subset of lung cancer patients.
  • Aberrant Cx43 protein expression localization is linked to tumor progression in lung cancer.